Company
United StatesBoehringer Ingelheim Roxane, Inc., Danbury, CT – FDA Inspections
Inspection records and compliance data for Boehringer Ingelheim Roxane, Inc. in Danbury, Connecticut. 2 FDA inspections on record, last inspected January 07, 2011.
Company Profile
This profile covers Boehringer Ingelheim Roxane, Inc. based in Danbury, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected November 10, 2008. Last inspected January 7, 2011.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 7, 2011 | NAI | Human Drugs · Drug Quality Assurance | 707872 |
| November 10, 2008 | NAI | Human Drugs · Drug Quality Assurance | 548151 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Boehringer Ingelheim Roxane, Inc.
FEI Number
1219767
Address
175 Briar Ridge Rd, Danbury, Connecticut 06810, United States
Country
United States
ID: ff6a43b9-fcc8-44c1-aee1-b927b9515098